Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) just unveiled an update.
Fisher & Paykel Healthcare Corporation Limited has announced its guidance for the first half of the 2026 financial year, projecting a revenue of approximately $1.075 billion and a net profit after tax of around $200 million, reflecting significant growth compared to the previous year. The company also maintains its full-year outlook, despite the impact of US tariffs on hospital products. Additionally, board director Pip Greenwood will retire, having contributed significantly to the company since 2017, and the process to appoint a new director will commence shortly.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a leading company in the design, manufacture, and marketing of products and systems for acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company’s products are distributed in over 120 countries worldwide.
For an in-depth examination of FSPKF stock, go to TipRanks’ Overview page.